Your browser doesn't support javascript.
loading
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.
Schwab, Claire; Ryan, Sarra L; Chilton, Lucy; Elliott, Alannah; Murray, James; Richardson, Stacey; Wragg, Christopher; Moppett, John; Cummins, Michelle; Tunstall, Oliver; Parker, Catriona A; Saha, Vaskar; Goulden, Nicholas; Vora, Ajay; Moorman, Anthony V; Harrison, Christine J.
Affiliation
  • Schwab C; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom;
  • Ryan SL; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom;
  • Chilton L; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom;
  • Elliott A; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom;
  • Murray J; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom;
  • Richardson S; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom;
  • Wragg C; Bristol Genetics Laboratory, Southmead Hospital, North Bristol National Health Service Trust, Bristol, United Kingdom;
  • Moppett J; Department of Paediatric Haematology and Oncology, Bristol Royal Hospital for Children, Bristol, United Kingdom;
  • Cummins M; Department of Paediatric Haematology and Oncology, Bristol Royal Hospital for Children, Bristol, United Kingdom;
  • Tunstall O; Department of Paediatric Haematology and Oncology, Bristol Royal Hospital for Children, Bristol, United Kingdom;
  • Parker CA; Children's Cancer Group, Manchester Academic Health Sciences Centre, Institute of Cancer, University of Manchester, Manchester, United Kingdom;
  • Saha V; Children's Cancer Group, Manchester Academic Health Sciences Centre, Institute of Cancer, University of Manchester, Manchester, United Kingdom; Department of Paediatric Oncology, Tata Translational Cancer Research Centre, Kolkata, India;
  • Goulden N; Department of Haematology, Great Ormond Street Hospital, London, United Kingdom; and.
  • Vora A; Department of Haematology, Sheffield Children's Hospital, Sheffield, United Kingdom.
  • Moorman AV; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom;
  • Harrison CJ; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom;
Blood ; 127(18): 2214-8, 2016 05 05.
Article de En | MEDLINE | ID: mdl-26872634

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie-lymphome lymphoblastique à précurseurs B / Protéines de fusion oncogènes / Transactivateurs / Récepteur au PDGF bêta Limites: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Langue: En Journal: Blood Année: 2016 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie-lymphome lymphoblastique à précurseurs B / Protéines de fusion oncogènes / Transactivateurs / Récepteur au PDGF bêta Limites: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Langue: En Journal: Blood Année: 2016 Type de document: Article Pays de publication: États-Unis d'Amérique